Kevin Lind (L) and Amit Munshi

October 28, 2020 09:18 AM EDT

Arena's Amit Munshi spins out his neuro sub into a biotech startup, with $56M for the baptism

John Carroll

Editor & Founder

Back in January, Arena Pharma $ARNA CEO Amit Munshi turned up at JP Morgan with ambitious plans for 2020. Near the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

view job offer post your job now

TRENDING NOW

Lack of detail in Trump's drug price plan raises more questions than answers

Updated: White House threatens ‘most favored nation’ plan to lower US drug prices, but many questions remain

Pharma investors brush off Trump’s ‘most favored nation’ plan as stocks rise

Roche could rethink $50B US expansion plan if new policies 'harm' operations

Exclusive: Patrick Hsu startup launches, looks beyond CRISPR for gene insertion technology

PBM overhaul and drug price negotiations make the cut in Republicans' tax bill